Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereof
US11649217B2 · kind B2 · utility
0Cited by
1References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 11, 2021 |
| Grant date | May 16, 2023 |
| Priority date | — |
| Expiry date | Feb 11, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to crystalline form CS1 and CS9 of a hypoxia-inducible factor prolyl hydroxylase inhibitor compound (I) GSK1278863, processes for preparation, and uses for preparing drugs treating and/or preventing anemia thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.